LY2584702

LY2584702 · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for LY2584702, covering 2018-07-16 to 2019-01-22. Get the full timeline:

Most recent: Clinical Trial Update: Single Dose Study in Healthy Participants to Investigate the Safety and Absorption of LY2584702 [Phase 1]